MSH|^~\&|SUT-APP|OFM|IIP-IIS-APP|IIP|20240405132213-0500||VXU^V04^VXU_V04|IIP-Transmit-8|P|2.5.1|||ER|AL|||||Z22^CDCPHINVS|Oregon Family Medicine|Immunization Integration Program
PID|1||4444^^^IIP-MPI-1^MR||McKay^Deborah^Charlotte^^^^L|Schroeder^^^^^^M|20230205|F||2054-5^Black or African American^CDCREC|600 Cherry Rd.^^Springfield^OR^97477^USA^P||^PRN^PH^^^541^5551236|||||||||2186-5^Not Hispanic or Latino^CDCREC||Y|2|||||N
PD1|||||||||||02^Reminder/recall - any method^HL70215|N|20240405|||A|20240126|20240405
NK1|1|McKay^Angeline^Ingrid^^^^L|MTH^Mother^HL70063|600 Cherry Rd.^^Springfield^OR^97477^USA^P|^PRN^PH^^^541^5551236
ORC|RE|1116^IIP-2|2227^IIP-2|||||||7824^Wyatt^Daniela^Jennifer^^^^^OFM-PI-1^L^^^PRN||654^Bradshaw^Ramon^Michael^^^^^OFM^L^^^MD|||||197028^Oregon Family Medicine^HL70362
RXA|0|1|20240405||58160-0825-43^HAVRIX^NDC^83^Hep A, ped/adol, 2 dose^CVX|0.5|mL^mL^UCUM||00^New immunization record^NIP001|7824^Wyatt^Daniela^Jennifer^^^^^OFM-PI-1^L^^^PRN|^^^OFM||||IIPVAXN11|20290927|SKB^GlaxoSmithKline^MVX|||CP|A
RXR|C28161^INTRAMUSCULAR^NCIT|LVL^Left Vastus Lateralis^HL70163
OBX|1|CE|30963-3^Vaccine funding source^LN|1|PHC70^Private funds^CDCPHINVS||||||F|||20240405
OBX|2|CE|64994-7^Vaccine funding program eligibility category^LN|1|V01^Not VFC eligible^HL70064||||||F|||20240405|||VXC40^Eligibility captured at the immunization level^CDCPHINVS
OBX|3|CE|69764-9^Document type^LN|3|253088698300004211211015^Hepatitis A Vaccine VIS - 10/15/2021^cdcgs1vis||||||F|||20240405
OBX|4|DT|29769-7^Date Vaccine Information Statement Presented^LN|3|20240405||||||F|||20240405